Bain Capital Life Sciences Fund II, L.P.

Track

Insider profile

Bain Capital Life Sciences Fund II, L.P.'s trades of NewAmsterdam Pharma Company NV's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-02 2025-12-02
PrS Proposed sale
77,379
409.87
US$4,011,054 		77,379 409.87 US$4,011,054
2025-07-24 2025-07-24
US Nuvalent Inc (NUVL)
PrS Proposed sale
39,192
207.68
US$978,273 		39,192 207.68 US$978,273
2024-12-11 2024-12-11
US Nuvalent Inc (NUVL)
PrS Proposed sale
47,818
396.46
US$1,212,354 		47,818 396.46 US$1,212,354